HCA Healthcare, Inc. (HCA)
- Previous Close
335.11 - Open
335.61 - Bid 329.97 x 800
- Ask 330.55 x 800
- Day's Range
328.46 - 335.35 - 52 Week Range
245.84 - 417.14 - Volume
448,449 - Avg. Volume
1,302,709 - Market Cap (intraday)
83.225B - Beta (5Y Monthly) 1.69
- PE Ratio (TTM)
14.75 - EPS (TTM)
22.28 - Earnings Date Jan 28, 2025 - Feb 3, 2025
- Forward Dividend & Yield 2.64 (0.79%)
- Ex-Dividend Date Dec 13, 2024
- 1y Target Est
406.30
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
www.hcahealthcare.com220,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HCA
View MorePerformance Overview: HCA
Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCA
View MoreValuation Measures
Market Cap
84.88B
Enterprise Value
126.88B
Trailing P/E
15.05
Forward P/E
13.61
PEG Ratio (5yr expected)
1.08
Price/Sales (ttm)
1.28
Price/Book (mrq)
--
Enterprise Value/Revenue
1.82
Enterprise Value/EBITDA
9.06
Financial Highlights
Profitability and Income Statement
Profit Margin
8.52%
Return on Assets (ttm)
11.51%
Return on Equity (ttm)
1,195.45%
Revenue (ttm)
69.62B
Net Income Avi to Common (ttm)
5.93B
Diluted EPS (ttm)
22.28
Balance Sheet and Cash Flow
Total Cash (mrq)
2.98B
Total Debt/Equity (mrq)
5,711.07%
Levered Free Cash Flow (ttm)
4.15B